Fungal endocarditis

Journal of Infection

Volumn 35, Issue 2, 1997, Pages 99-103

  Ellis, M ^a  

^a HCI International Medical Centre   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE;

BLOOD CULTURE; CLINICAL FEATURE; ECHOCARDIOGRAPHY; ENDOCARDITIS; HEART VALVE; HUMAN; MORTALITY; MYCOSIS; PATHOLOGY; PROPHYLAXIS; SERODIAGNOSIS; SHORT SURVEY;

EID: 0030657849     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-4453(97)91347-5     Document Type: Review

References (42)

1. Sande AM, Bowman CR, Calderone RA. Experimental Candida albicans endocarditis: charaterisation of the disease and response to therapy. Infect Immun 1977; 17: 140-147.
2. Carrizosa J, Kohn C, Levison ME. Experimental aspergillus endocarditis in rabbits: J Lab Clin Med 1975; 86: 746-753.
3. Rubenstein E, Eduardo R et al. Fungal endocarditis: analysis of 24 cases and reviews of the literature. Medicine 1975; 54: 331-344.
4. Seelig MS, Goldberg P et al. Fungal endocarditis: patients at risk and their treatment. Postgraduate Medical Journal 1979; 55: 632-641.
5. Robboy SJ, Kaiser J. Pathogenesis of fungal infection on heart valve prostheses. Human Pathology 1975; 6: 711-715.
6. Scheld WM, Strunk RW et al. Microbial adhesion to fibronectin in vitro correlates with production of endocarditis in rabbits (42205). Proceedings of the Society for Experimental Biology and Medicine 1985; 180: 474-482.
7. Bendel CM, St Sauver J et al. Epithelial adhesion in yeast species: correlation with surface expression of the integrin analog. J Infect Dis 1995; 171: 1660-1663.
8. Gustafson KS, Vercellotti GM et al. Molecular mimicry in Candida albicans. Role of an integrin analogue in adhesion of the yeast to human endothelium. J Clin Invest 1991; 87: 1896-1902.
9. Santoni G, Birarelli P et al. An alpha 5 beta 1-like integrin receptor mediates the binding of less pathogenic Candida species to fibronectin. J Med Microbiol 1995; 43: 360-367.
10. Rotrosen D, Calderone RA et al. Adherence of Candida species to host tissues and plastic surfaces. Rev Infect Dis 1986; 8: 73-85.
11. Skerl KG, Calderone A et al. Platelet interactions with Candida albicans. Infect Immun 1981; 34: 938-943.
12. Calderone RA, Cihlar RL. Yeast adhesion in the pathogenesis of endocarditis due to Candida albicans: studies with adherence-negative mutants. J Infect Dis 1985; 152: 710-715.
13. Scheld WM, Calderone RA et al. Influence of performed antibody on the pathogenesis of experimental Candida albicans endocarditis. Infect Immun 1983; 40: 950-955.
14. Maisch PA, Calderone RA. Adherence of Candida albicans to a fibrinplatelet matrix formed in vitro. Infect Immun 1980; 27: 650-656.
15. Hawser SP, Douglas LJ. Biofilm formation by Candida species on the surface of catheter materials in vitro. Infect Immun 1994; 62: 915-921.
16. Calderone RA, Rotondo MF. Candida albicans endocarditis: ultrastructural studies of vegetation formation. Infect Immun 1978; 20: 279-289.
17. Marrie TJ, Cooper JH. Ultrastructure of Candida parapsilosis endocarditis. Infect Immun 1984; 45: 390-398.
18. Emori TG, Gaynes RP. An overview of nosocomial infections, including the role of the microbiology laboratory. Clin Microbiol Rev 1993; 6: 428-442.
19. Forsgren A, Schmeling D, Quie PG. Effect of tetracycline on the phagocyte function of human leucocytes. J Infect Dis 1974; 130: 412-415.
20. Bross J, Talbot GH et al. Risk factors for noscomial candidemia: a case control study in adults without leukemia. Am J Med 1989; 87: 614-620.
21. Ellis ME, Qadri SMH et al. The effect of fluconazole as prophylaxis for netropenic patients on the isolation of Candida spp. from surveillance cultures. Journal of Antimicrobial Chemotherapy 1994; 33: 1223-1228.
22. Ellis ME, Clink H et al. Controlled study of fluconazole in the prevention of fungal infections in neutropenic patients with haematological malignancies and bone marrow transplant recipients. Eur J Clin Microbiol Infect Dis 1994; 13: 3-11.
23. Wingard JR. Importance of Candida species other than C. albicans as pathogens in oncology patients. Clin Infect Dis 1995; 20: 115-125.
24. Sanchez V, Vazquez JA et al. Epidemiology of nosocomial acquisition of Candida lusitaniae. J Clin Microbiol 1992; 30: 3005-3008.
25. Mehta G. Aspergillus endocarditis after open heart surgery: an epidemiological investigation. J Hasp Infect 1990; 15: 245-253.
26. Muehrcke DD et al. Surgical and long-term antifungal therapy for fungal prosthetic valve endocarditis. Ann Thorac Surg 1995; 60: 538-543.
27. Ellis ME. Fungal endocarditis - an 18 year review (in preparation).
28. Woods GL, Wood RP, Shaw BW Jr. Aspergillus endocarditis in patients without prior cardiovascular surgery: report of a case in a liver transplant recipient and review. Rev Infect Dis 1989; 11: 263-272.
29. Goodwin RA, Shapiro JL. Disseminated histoplasmosis: clinical and pathologic correlations. Medicine 1980; 59: 22-26.
30. Rubinstein E, Lang R. Fungal endocarditis. European Heart Journal 1995; 16 (Suppl. B): 84-89.
31. Vo NM, Russell JC et al. Mycotic emboli of the peripheral vessels: analysis of forty-four cases. Surgery 1981; 90: 541-545.
32. Walsh TJ, Hathorn JW et al. Detection of circulating candida enolase by immunoassay in patients with cancer and invasive candidiasis. New Eng J Med 1991; 324: 1026-1031.
33. Polanco AM, Rodriguez-Tudela JL, Martinez-Suarez JV. Specific detection of pathogenic fungi in human blood by polymerase chain reaction. (Abstract) Second meeting of the European Confederation of Medical Mycology. Brussels 1995.
34. Erjavec Z, Brinker M, Apperlo-Renkema A et al. Fast identification of Aspergillus fungatus by RAPD PCR Technology. (Abstract). Second meeting of the European Confederation of Medical Mycology. Brussels 1995.
35. Kammer RB, Utz JP. Aspergillus species endocarditis: the new face of a not so rare disease. Am J Med 1974; 56: 506-521.
36. Denning SW, Stevens DA. Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases. Rev Infect Dis 1990; 12: 1147-1201.
37. Muehrcke DD, Lytle BW, Cosgrove DM. Surgical and long-term antifungal therapy for fungal prosthetic valve endocarditis. Ann Thorac Surg 1995; 60: 538-543.
38. Muehrcke DD. Fungal prosthetic valve endorcaditis Seminars in Thoracic and Cardiovascular Surgery 1995; 7: 20-24.
39. Ghannoum MA. Is antifungal susceptibility testing useful in guiding fluconazole therapy? Clin Infect Dis 1996; 22: S161-S165.
40. Longman LP, Hibbert SA, Martin MV. Efficacy of fluconazole in prophylaxis and treatment of experimental Candida endocarditis. 1990. 12 (Suppl. 3): S294-S298.
41. Fang G, Keys TF. Prosthetic valve endocarditis resulting from nosocomial bacteremia. A prospective, multi-centre study. 1993; 119 (7 Pt. 1): 560-567.
42. Pfaller MA. Nosocomial candidiasis: emerging species, reservoirs and modes of transmission. Clin Infect Dis 1996; 22 (Suppl. 2): S89-S94.